Aspira Women's Health Inc. (AWHL): Capital Expenditures
$16.0K
Year ended 2025-12-31
-59.0%
3-year compound annual growth
-49.6%
5-year compound annual growth
-24.9%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $16.0K | -56.8% | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | $37.0K | +54.2% | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $24.0K | -89.7% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $232.0K | +26.1% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $184.0K | -62.4% | 2023-10-26, From 2021-01-01 |
| 2020-12-31 | $490.0K | +268.4% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $133.0K | +17.7% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $113.0K | +88.3% | 2020-04-07, From 2018-01-01 |
| 2017-12-31 | $60.0K | -95.2% | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | $1.26M | +347.2% | 2018-03-13, From 2016-01-01 |
| 2015-12-31 | $282.0K | +9.3% | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $258.0K | -19.6% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $321.0K | n/m | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $14.0K | -85.9% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $99.0K | -45.0% | 2013-03-01, From 2011-01-01 |
| 2010-12-31 | $180.0K | n/a | 2012-03-27, From 2010-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $16.0K | -56.8% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $3.19M | +517.2% |
| Immucell Corp (ICCC) | 2025-12-31 | $1.25M | +168.5% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $1.15M | +2.0% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $89.6K | -67.7% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $2.71M | +41.4% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $1.13M | -80.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $51.30M | -51.0% |
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $188.20M | -3.5% |
Compare AWHL, IMDX, ICCC, TKNO side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗